Despite the success of COVID-19 vaccines, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have emerged that can cause......
Kaplonek, P; Cizmeci, D; Kwatra, G; Izu, A; Lee, JSL; Bertera, HL; Fischinger, S; Mann, C; Amanat, F; Wang, WJ; Koen, AL; Fairlie, L; Cutland, CL; Ahmed, K; Dheda, K; Barnabas, SL; Bhorat, QE; Briner, C; Krammer, F; Saphire, EO; Gilbert, SC; Lambe, T; Pollard, AJ; Nunes, M; Wuhrer, M; Lauffenburger, DA; Madhi, SA; Alter, G
Alter, G (通讯作者),Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.;Madhi, SA (通讯作者),Univ Witwatersrand, Fac Hlth Sci, South African Med Res Council, Vaccines & Infect Dis Analyt Res Unit, Johannesburg, South Africa.;Madhi, SA (通讯作者),Univ Witwatersrand, Natl Res Fdn South African Res Chair Initiat Vacci, Dept Sci & Innovat, Johannesburg, South Africa.;Madhi, SA (通讯作者),Univ Witwatersrand, Fac Hlth Sci, African Leadership Vaccinol Expertise, Johannesburg, South Africa.
NATURE IMMUNOLOGY, 2023; 24 (7): 1161